Zhengqiang Wang

27PUBLICATIONS
37CO-AUTHORS
PharmacogenomicsMedical virologyProteins and peptidesPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 20, 2026
Breakthrough Design of Highly Potent Antivirals Against Wild-Type HIV-1 and Lenacapavir-Resistant M66I Variant.

|Jun 24, 2026
3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitors.

|Jun 18, 2026
Discovery and characterization of a hydroxypyridone-3-carboxamide analog as an antiviral lead against orthopoxviruses.

|Mar 27, 2026
Damaging the conical morphology of HIV-1 capsid by targeting the FG-binding pocket and disfavoring pentameric subunits needed for core closure.

William M McFadden, Karen A Kirby, Zachary C Lorson

|Jan 09, 2026
Design, synthesis and profiling of highly potent antivirals targeting emerging drug-resistant HIV-1 variants.

Nicolas Jamey, D M Nirosh Udayanga, Huanchun Zhang

|Jan 09, 2026
Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals.

Karen A Kirby, William M McFadden, Lei Wang

Pageof 5

Frequent Collaborators

7 joint publications

Karen A Kirby

6 joint publications

Stefan G Sarafianos

4 joint publications

Philip R Tedbury

4 joint publications

Jacob P Mahoney